Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells
Jamal Mohammadian, Shiva Mahmoudi, Pirouz Pourmohammad, Mohammad Bagher Pirouzpanah, Fatemeh Salehnia, Nazila Fathi Maroufi, Nasser Samadi, Mehdi Sabzichi
Topics & Concepts
SurvivinDoxorubicinApoptosisDAPIMTT assayCytotoxicityCancer cellCancer researchChemistryPharmacologyBiologyMedicineCancerIn vitroChemotherapyBiochemistrySurgeryInternal medicineCytokine Signaling Pathways and InteractionsCancer Mechanisms and TherapySynthesis and biological activity